Trans-Pacific Technology Fund (TPTF)
The Trans-Pacific Technology Fund (TPTF) is a venture capital fund that focuses on investing in innovative companies poised to influence the future of global business. TPTF actively collaborates with the leadership of its portfolio companies across various regions to foster their growth. The fund emphasizes the importance of skilled entrepreneurs in transforming innovative concepts into successful businesses. Beyond providing capital, TPTF positions itself as a dedicated partner, utilizing its international resources and domain expertise to support entrepreneurs. The fund targets disruptive platform technologies in sectors such as advanced materials, health and life sciences, information and communication technology, the Internet of Things, and robotics and automation. With a multi-stage investment strategy, TPTF engages with companies at different growth stages, aiming to invest across Asia, North America, and Europe through its extensive network of global partners.
Top Stages
9 past transactions
Rey.id
Seed Round in 2024
Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.
Rey.id
Seed Round in 2022
Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.
Rey.id
Pre Seed Round in 2021
Rey is a pioneering health and life insurance provider in Indonesia, established in 2021. It operates on a digital platform designed to offer comprehensive life, health, and critical illness insurance, distinguishing itself from traditional insurance models. Rey emphasizes a holistic approach to healthcare, integrating wellness and preventative care into its offerings while prioritizing the quality of services provided to its members. By leveraging technology, Rey aims to simplify the insurance experience, eliminating cumbersome paper processes and providing a personalized, data-driven approach. The company's mission is to transform the perception of insurance from a mere necessity into a desirable service that enhances the overall well-being of its users. Rey's diverse team is committed to reimagining the life and health insurance landscape in Indonesia, making it more accessible and aligned with the needs of its customers.
Prixa
Seed Round in 2021
Prixa is a pioneering digital healthcare company based in Jakarta, Indonesia, founded in 2019. It provides a comprehensive health management platform that enables patients to manage their health more effectively and access a range of services from a single interface. Utilizing artificial intelligence technology, Prixa offers telemedicine, medical appointments, pharmacy delivery, and laboratory testing, while also delivering health-related content. The platform aims to humanize health management by focusing on accessible and affordable healthcare services tailored for insurance companies, corporations, and government entities, ultimately helping to reduce claims and healthcare costs.
Finch Therapeutics
Series D in 2020
Finch Therapeutics develops microbial therapies to treat serious medical conditions driven by microbiome disruption. It uses machine learning algorithms to identify microbes from successful clinical datasets, enabling early retirement of translational risk.
Finch Therapeutics
Series C in 2019
Finch Therapeutics develops microbial therapies to treat serious medical conditions driven by microbiome disruption. It uses machine learning algorithms to identify microbes from successful clinical datasets, enabling early retirement of translational risk.
Zymergen
Series C in 2018
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.
Heal
Series C in 2018
Heal is a healthcare provider focused on delivering value-based, in-home primary care primarily to seniors on Medicare and select Medicare Advantage plans. The company emphasizes the importance of patient comfort by offering services in the familiar environment of patients' homes. Board-certified doctors and nurse practitioners at Heal dedicate ample time to each patient, fostering strong relationships and ensuring thorough, unrushed care. Heal addresses a wide range of healthcare needs, from preventive services like flu shots and annual physicals to the management of chronic conditions and treatment of common illnesses. Additionally, the company provides telemedicine options and remote health monitoring, facilitating easy access to care when needed. Patients can schedule appointments conveniently through phone support, with availability seven days a week, including weekends and holidays.
Kata.ai
Series A in 2017
Founded in 2015, Kata.ai specializes in Conversational Artificial Intelligence, focusing on enhancing human-machine collaboration through advanced Natural Language Processing. Its proprietary platform enables businesses to create engaging chatbots across various messaging channels, improving customer engagement and streamlining communication processes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.